One Data, Two Data, Three Data, More…

Out guest post today comes from Jim Curtis, CRO, Remedy Health Media  Over the last year, I have attended my fair share of conferences, meetings, lectures, symposiums, summits…(you get the picture). Each of them focused on the topic of Big Data. We hear industry leaders discussing the importance of it, sales people raving abouthaving so much of it, marketers wanting to take advantage of it. If one were to search the term “Big Data” right now, they would receive over 684 million results from Google alone. Now that is big! Despite the prevailing fascination with Big Data and what it is, I believe the real question for pharmaceutical marketers and publishers alike is: how can we turn Big Data into small useful data? Meaning, what data is most important and how can it be used to create better marketing programs as well as better health outcomes? Accountable Care enter stage left. Although payers and providers have been storing and harvesting patient data for some time, the enhanced focus on Accountable Care makes it more accessible and more relevant to patients and manufacturers. We now have the opportunity, through EHRs and Software Management Systems, to collectively track patient history, treatment, and follow-up care to ensure the best health outcomes. According to an American Journal of Health-System Pharmacy article, Cigna used digital adherence tools to increase adherence and reduce medical costs:           &nbs...
Source: ePharma Summit - Category: Medical Marketing and PR Tags: 2013 epharma summit big data Digital Marketing for Pharma Source Type: blogs